AstraZeneca PLC Will Buy CinCor for Cardiorenal Asset
[ad_1] By Joe Hoppe AstraZeneca PLC said Monday that it has agreed to buy CinCor Pharma, Inc., acquiring global rights to the latter’s baxdrostat cardiorenal drug for an upfront transaction…
AstraZeneca’s Imfinzi plus Imjudo recommended for approval in the EU
[ad_1] AstraZeneca PLC said Monday that its Imfinzi and Imjudo combinations have been recommended for marketing authorization in the European Union for advanced liver and lung cancer. The Anglo-Swedish pharma…